The chemical name for this compound is 2,2,4,4,6,6-Hexamethyl-1,3,5-trioxane-1,3,5-tricarboxylic acid mono-tert-butyl ester.

Pentagastrin is a synthetic pentapeptide that has effects like gastrin. When given parenterally it stimulates the secretion of gastric acid, pepsin and intrinsic factor.

Pentapeptide-18 is a synthetic peptide consisting of alanine, glycine, leucine, phenylalanine and tyrosine.

Leuphasyl is an amid peptide, a delta opioid agonist, is a degradation resistant long-acting Leu-enkephalin analog used to study the signaling pathway of delta opioid receptors. It is a potent, long-acting Leu-enkephalin analog that is resistant to enzymatic degradation

Pentapeptide-25 is a synthetic peptide containing arginine, glycine, leucine, lysine, and valine

Pentapeptide-3 is a synthetic peptide that can inhibit muscle contractions as competitive antagonist at the muscle-type nicotinic acetylcholine receptor.

Pentapeptide-31 is the synthetic peptide consisting of alanine, glutamine, glycine, leucine and serine.

Pentostatin is a purine analogue and antineoplastic agent used in the therapy of hairy cell leukemia and T cell lymphomas. Pentostatin is associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of severe acute liver injury with jaundice.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Potent inhibitor of PCSK9 binding to LDL receptor (IC50 = 0.8 μM). Restores LDL uptake in HepG2 cells treated with PCSK9.

Pep-1 (uncapped) is a cell-penetrating peptide.

Pep-1 is one of the synthetic cell-penetrating peptides (CPPs), which has been successfully used to deliver a variety of proteins and other biopharmaceutical macromolecules into cells in a non-disruptive way. It is a CPP with primary amphipathicity that comprises a tryptophan-rich so-called ‘hydrophobic’ domain, a hydrophilic domain derived from an NLS (nuclear localization signal) of […]

Pep1-AGL is analog of Pep1-TGL (Cat. No. 1601), and a peptide containing the ‘TGL’ motif that corresponds to the C-terminus of the AMPA receptor GluA1 subunit.

Pep1-TGL is a peptide containing the ‘TGL’ motif that corresponds to the C-terminus of the AMPA receptor GluR1 subunit.

Selective peptide inhibitor of GluR2 subunit (at the C-terminal PDZ site) binding to PICK1, which does not have an effect on binding of GluA2 to GRIP or ABP, and does not increase AMPA current amplitude or affect long term depression (LTD).

Selective peptide inhibitor of GluR2 subunit (at the C-terminal PDZ site) binding to PICK1, which does not have an effect on binding of GluA2 to GRIP or ABP, and does not increase AMPA current amplitude or affect long term depression (LTD).

pep2-SVKE is inactive control peptide analog of pep2-SVKI, and an inhibitor peptide that corresponds the C-terminus of the GluA2 AMPA receptor subunit.

Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit that inhititss binding of GluA2 (at the C-terminal PDZ site) to glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases AMPA receptor-mediated currents amplitude and blocks long-term depression (LTD).

AMPA (GluR2) receptor inhibitor peptide that inhibits the interaction between the C-terminus of the GluR2 subunit and N-ethylmaleimide-sensitive fusion protein (NSF). It reduces AMPA currents

Myristoylated form of Pep2m; Cell-permeable inhibitor of the interaction between AMPA receptor and N-ethylmaleimide-sensitive fusion protein (NSF).

pep4c is an inactive control peptide analog of pep2m, and a peptide inhibitor of the interaction between the c-terminus of the glur2 (ampa receptor) subunit and n-ethylmaleimide-sensitive fusion protein (nsf).

Pepstatin (Pepstatin A) is a specific aspartic protease inhibitor produced by actinomycetes, with IC50s of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM and 260 nM for hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease and hemoglobin-acid protease, respectively. Pepstatin Ammonium also inhibits HIV protease.

Peptide 401, a potent mast cell degranulating factor from bee venom, suppresses the increased vascular permeability due to intradermal injection of various smooth muscle spasmogens (histamine, and 5-HT).

Peptide C105Y, a synthetic and cell-penetrating peptide based on the amino acid sequence corresponding to residues 359-374 of α1-antitrypsin, enhances gene expression from DNA nanoparticles.